Skip to content
Companies

Zucara Therapeutics

Daily drug to prevent insulin-induced hypoglycemia

Raised to date

Not disclosed

No Form D filings on record

Investors
3

About

Zucara Therapeutics Inc. is a pioneering life sciences company focused on diabetes treatment, specifically dedicated to developing innovative solutions to combat hypoglycemia in individuals with diabetes. Through advanced therapeutics, Zucara aims to improve the quality of life for those affected by insulin-dependent diabetes by providing preventive measures against the potentially dangerous side effects of insulin therapy.

What distinguishes Zucara is its commitment to developing the first once-daily therapeutic specifically to prevent insulin-induced hypoglycemia, addressing a significant unmet medical need in diabetes management.

Product

ZT-01

Diabetes Therapy

ZT-01 is Zucara Therapeutics' lead drug candidate, designed as a first-in-class treatment specifically aimed at preventing incidents of insulin-induced hypoglycemia. This once-daily therapeutic is geared towards re-establishing normal hormonal responses to glucose levels, thereby enhancing patient safety and therapeutic efficacy.

  • Once-daily administration
  • Inhibits somatostatin to regulate glucagon response
  • Targeted towards Type 1 and Type 2 diabetes patients

Built for

Individuals with Type 1 and insulin-dependent Type 2 diabetes